Metraipolis › archive › dc_99fa1b9ff463

FDA approval of mitomycin hydrogel (Zusduri): a new non-surgical era for non-muscle-invasive bladder cancer (NMIBC) — Europe PMC PMID:42433776

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42433776
DOI
10.1097/ms9.0000000000005163
License (as archived)
solo-consultazione
Archived
2026-10-31T15:56:33.389Z
SHA-256 of the archived text
fbce9eaec712694a7ed8a73853d0c188a7d94a756f12d831e30016f57056d54d
Stable URL of this page
https://metraipolis.com/documento/dc_99fa1b9ff463

How to cite

FDA approval of mitomycin hydrogel (Zusduri): a new non-surgical era for non-muscle-invasive bladder cancer (NMIBC) — Europe PMC PMID:42433776 — Europe PMC (en), https://europepmc.org/article/MED/42433776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99fa1b9ff463 (Metraipolis archive dc_99fa1b9ff463, sha256 fbce9eaec712694a7ed8a73853d0c188a7d94a756f12d831e30016f57056d54d)
BibTeX
@misc{dc99fa1b9ff463,
  title = {FDA approval of mitomycin hydrogel (Zusduri): a new non-surgical era for non-muscle-invasive bladder cancer (NMIBC) — Europe PMC PMID:42433776},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42433776},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99fa1b9ff463; sha256 fbce9eaec712694a7ed8a73853d0c188a7d94a756f12d831e30016f57056d54d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433776. Agents can read the archived copy with the MCP tool read_document.